Carrier of Acinetobacter baumannii, unspecified
ICD-10 Z22.349 is a billable code used to indicate a diagnosis of carrier of acinetobacter baumannii, unspecified.
Z22.349 is used to classify individuals who are carriers of Acinetobacter baumannii, a bacterium often associated with healthcare-associated infections. Carriers may not exhibit symptoms but can transmit the bacteria to others, particularly in healthcare settings. Understanding the social determinants of health, such as socioeconomic status, access to healthcare, and living conditions, is crucial as these factors can influence the risk of transmission and the effectiveness of preventive measures. Preventive care for carriers includes education on hygiene practices, screening for infections, and monitoring for potential outbreaks. Screening may involve cultures or other diagnostic tests to identify the presence of the bacteria, while aftercare focuses on managing any potential infections and ensuring that carriers understand their role in preventing transmission. Proper documentation of carrier status is essential for effective public health interventions and to guide clinical decision-making.
Documentation should include patient history, risk factors for Acinetobacter baumannii, and any preventive measures taken.
Routine checkups where carrier status is identified, screenings for infections, and aftercare for patients with potential exposure.
Consideration of social determinants such as living conditions and access to healthcare resources.
Documentation should include population-level data, surveillance reports, and outbreak management strategies.
Epidemiological studies, community health screenings, and preventive health campaigns.
Focus on tracking health status and implementing community-wide preventive measures.
Used in conjunction with Z22.349 when screening for the presence of the bacteria.
Document the reason for testing and any relevant patient history.
Primary care providers should ensure that screening aligns with preventive health guidelines.
Documentation should include confirmation of carrier status, any relevant patient history, and preventive measures discussed or implemented to prevent transmission.
